CIK 0000914475 · Large accelerated filer
NEUROCRINE BIOSCIENCES INC
Sign in to watch- Ticker
- NBIX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330525145
- Phone
- (858) 617-7600
- Business address
- 6027 EDGEWOOD BEND COURT, SAN DIEGO, CA, 92130
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,162,347
- in 4 filings, $3.2M under 10b5-1 plans
Net −$3,162,347. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-12-06 | Lippoldt Darin Chief Legal Officer | Option exercise 10b5-1 | +20,830 | $43.24 | $901K | 56,712 |
| 2023-12-06 | Lippoldt Darin Chief Legal Officer | Sale 10b5-1 | −20,830 | $119.86 | $2.5M | 35,882 |
| 2023-12-06 | Lippoldt Darin Chief Legal Officer | Option exercise · Non-Qualified Stock Option 10b5-1 | −20,830 | $43.24 | $901K | 4,376 |
| 2023-12-01 | LYONS GARY A Director | Option exercise 10b5-1 | +5,000 | $12.98 | $65K | 208,697 |
| 2023-12-01 | LYONS GARY A Director | Sale 10b5-1 | −5,000 | $116.77 | $584K | 203,697 |
| 2023-12-01 | LYONS GARY A Director | Option exercise · Non-Qualified Stock Option 10b5-1 | −5,000 | $12.98 | $65K | 0 |
| 2023-11-29 | Onyia Jude Chief Scientific Officer | Sale 10b5-1 | −2,331 | $113.57 | $265K | 11,732 |
| 2023-11-27 | Lippoldt Darin Chief Legal Officer | Sale 10b5-1 | −10,919 | $112.27 | $1.2M | 35,882 |
| 2023-11-16 | SHERWIN STEPHEN A Director | Gift | −2,750 | 22,305 | ||
| 2023-10-02 | Boyer David W. Chief Corp. Affairs Officer | Sale 10b5-1 | −1,437 | $112.68 | $162K | 4,894 |
| 2023-09-12 | LYONS GARY A Director | Option exercise 10b5-1 | +5,000 | $12.98 | $65K | 208,697 |
| 2023-09-12 | LYONS GARY A Director | Sale 10b5-1 | −5,000 | $115.02 | $575K | 203,697 |
| 2023-09-12 | LYONS GARY A Director | Option exercise · Non-Qualified Stock Option 10b5-1 | −5,000 | $12.98 | $65K | 5,000 |
| 2023-09-01 | LYONS GARY A Director | Option exercise 10b5-1 | +5,000 | $12.98 | $65K | 208,697 |
| 2023-09-01 | LYONS GARY A Director | Sale 10b5-1 | −5,000 | $110.06 | $550K | 203,697 |
| 2023-09-01 | LYONS GARY A Director | Option exercise · Non-Qualified Stock Option 10b5-1 | −5,000 | $12.98 | $65K | 10,000 |
| 2023-09-01 | Cooke Julie Chief Human Resources Officer | Sale 10b5-1 | −824 | $110.93 | $91K | 17,263 |
| 2023-08-30 | Boyer David W. Chief Corp. Affairs Officer | Sale 10b5-1 | −1,295 | $106.90 | $138K | 4,898 |
| 2023-08-30 | Boyer David W. Chief Corp. Affairs Officer | Sale 10b5-1 | −1,438 | $108.22 | $156K | 3,460 |
| 2023-08-30 | Lippoldt Darin Chief Legal Officer | Gift | −190 | 46,801 |
Page 43 of 49 · 963 trades